General Discussion
In reply to the discussion: Holy Shit! New Law: Drug Companies exempt from Lawsuits -Supreme Court Ruling [View all]godai
(2,902 posts)The observed average differences between reference and generic products for AUC was 3.5% (JAMA,
Sept. 4, 1987, Vol. 258, No. 9). The second survey included 127
bioequivalence studies submitted to the agency in 273 ANDAs approved in 1997.
The three measures reviewed include AUC(0-t), AUC(0-inf), and Cmax. The observed
average differences between the reference and generic products were + 3.47%
(SD 2.84) for AUC(0-t), + 3.25% (SD 2.97) for AUC(0-inf), and + 4.29% (SD 3.72)
for Cmax (JAMA, Dec. 1, 1999, Vol. 282, No. 21).
http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm071436.pdf page x
-----------------------------------------------------------------
Generics aren't 'exactly identical' anymore than innovator separate lots of product are 'exactly identical'. Think about that. It's important to understand.